医药股早盘持续走低，科兴制药、生物谷跌超11%，奥翔药业、申联生物、安科生物、众生药业、海创 药业等跌超6%。 ...

截至8月1日收盘，动物疫苗概念上涨2.22%，位居概念板块涨幅第1，板块内，13股上涨，申联生物20% 涨停，永顺生物、科兴制药、金河生物等涨幅居前，分别上涨6.32%、4.08%、3.32%。跌幅居前的有国 药现代、生物股份、中牧股份等，分别下跌0.70%、0.58%、0.52%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 动物疫苗 | 2.22 | 中船系 | -2.54 | | DRG/DIP | 1.87 | 兵装重组概念 | -1.90 | | BC电池 | 1.71 | 国产航母 | -1.45 | | 禽流感 | 1.62 | 民爆概念 | -1.19 | | ERP概念 | 1.61 | 可燃冰 | -1.14 | | 医疗废物处理 | 1.61 | 国家大基金持股 | -0.86 | | TOPCON电池 | 1.53 | 足球概念 | -0.78 | | 烟草 | 1.53 | 稀土永磁 | -0.73 | | 医药电商 | 1.51 | 中字头股票 | -0.73 | | MLOp ...

证券之星消息，8月1日生物制品板块较上一交易日下跌0.14%，三元基因领跌。当日上证指数报收于 3559.95，下跌0.37%。深证成指报收于10991.32，下跌0.17%。生物制品板块个股涨跌见下表： 从资金流向上来看，当日生物制品板块主力资金净流出2.78亿元，游资资金净流入1.06亿元，散户资金净 流入1.72亿元。生物制品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 000534 | 万泽股份 | 1.16/Z | 26.21% | -4287.29万 | -9.73% | -7264.75万 | -16.48% | | 688136 科兴制药 | | 6989.39万 | 8.67% | -5687.02万 | -7.05% | -1302.37万 | -1.61% | | 300841 | 康华生物 | 5257.55万 | 6.19% | -880.24万 | -1.04 ...

Investment Rating - The report indicates a positive outlook for the autoimmune therapy market, suggesting significant growth potential and investment opportunities in the sector [8]. Core Insights - The autoimmune market is the second largest after oncology, with a global market size of $132.3 billion in 2022, projected to reach $176.7 billion by 2030, reflecting a compound annual growth rate (CAGR) of 3.68% from 2022 to 2030 [8]. - The report highlights the potential for multi-target interventions to enhance treatment efficacy in autoimmune diseases, transitioning from monoclonal antibodies to bispecific and multispecific antibodies [19]. - The report emphasizes the significant market space for autoimmune therapies in China, where the autoimmune market size was only $2.9 billion in 2022, representing just 8% of the oncology market size of $34.7 billion, indicating substantial room for growth [8]. Market Overview - The global autoimmune drug market is expected to grow significantly, with the market size projected to increase from $1,323 million in 2022 to $1,767 million by 2030 [8]. - The report provides a detailed analysis of various autoimmune diseases, their prevalence, and the corresponding patient populations globally, including conditions like atopic dermatitis, chronic obstructive pulmonary disease, and rheumatoid arthritis [6][11]. Clinical Research Progress - The report outlines advancements in clinical research for dual-target and multi-target therapies, indicating a shift towards more effective treatment options for complex autoimmune diseases [19][22]. - It discusses the development of several blockbuster monoclonal antibody drugs in the autoimmune sector, with projected sales for top drugs in 2024, including Dupilumab at $14.15 billion and Risankizumab at $11.72 billion [9]. Key Companies to Watch - The report identifies key companies involved in the development of autoimmune therapies, including Sanofi, AbbVie, and Johnson & Johnson, highlighting their leading products and market positions [9][25].

【导读】创新药概念股大涨，硅能源板块异动拉升 中国基金报记者 李智 一起来看下最新的市场情况及资讯。 8月1日早盘，A股市场涨跌不一。截至发稿，沪指跌0.02%，深成指涨0.45%，创业板指涨0.59%。 从板块上来看，创新药概念股大涨，制药、生物科技、医疗保健板块震荡走高，硅能源概念股盘中异动拉升；航天军工、石油天然气、稳定币等板块震荡 走低。 | | | Wind热门概念指数 | | | | | Wind中国行业指数 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 钙钛矿电池 | TOPcon电池 | 中药 | 硅能源 | BC电池 | 航空 | 教育 | 制药 | 发电设备 | 汽车 | | 3.09% | 2.88% | 2.72% | 2.58% | 2.57% | 1.74% | 1.67% | 1.34% | 1.27% | 1.26% | | 光伏屋顶 2.57% | HJT电池 2.52% | 光伏 2.48% | SPD 2.46% | 光伏逆变器 2.42% | 石油化工 1.00% | 造紙 0 ...

A股市场生物疫苗股走强，其中，申联生物涨超10%，环球印务10CM涨停，冠昊生物、科兴制药涨超 7%，塞力医疗涨超5%，康乐卫士、金河生物、蔚蓝生物涨超4%，永顺生物、德展健康、君正集团、康 华生物涨超3%。 责任编辑：栎树 消息面上，基孔肯雅热诊疗方案2025年版发布，预防主要措施包括：及时清除蚊虫孳生地，降低蚊媒密 度；个人应使用蚊香、驱避剂、蚊帐等方式驱蚊、灭蚊和防蚊；前往基孔肯雅热流行区的旅行者要提高 防范意识，防止在境外感染基孔肯雅热。目前我国尚无可供使用的基孔肯雅病毒疫苗。有消息称佛山顺 德区乐从镇开展基孔肯雅热病毒免费核酸筛查，社区医生称主要针对病例同住人或家属。 | 代码 | | | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 688098 | 申联生物 | 1 | 10.33 | 32.03亿 | 42.60 | | 002799 | 环球印务 | 1 | 9.96 | 32.52 Z | 34.04 | | 300238 | 冠昊生物 | t | 7.70 | 49.69 Z | 55.65 | | 603 ...

| 代码 | | | 涨幅％ ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 300289 | 1 利德曼 | | 20.03 | 45.97 Z | 72.45 | | 600513 | 联环药业 | 秦 | 9.98 | 55.38 Z | 97.68 | | 688068 | 热景生物 | ﮨ | 9.25 | 198亿 | 244.50 | | 002317 | 众生药业 | - | 7.58 | 183亿 | 80.32 | | 688062 | | 迈威牛物-l 1 | 5.62 | 146亿 | 80.45 | | 688136 | | 科兴制药 t | 5.60 | 113亿 | 157.63 | | 002076 | *ST星米 | - | 4.86 | 21.52亿 | -19.17 | | 688221 | | 前沿牛物-L ↑ | 4.52 | 84.06亿 | 129.92 | | 300497 | 富祥药业 | | 3.59 | 57.20亿 | 24.70 | | 603718 | 海利生物 | | 3.37 ...

有消息称佛山顺德区乐从镇开展基孔肯雅热病毒免费核酸筛查，社区医生称主要针对病例同住人或家 属。 | 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 688098 | 申联生物 | 1 = | 10.33 | 32.03亿 | 42.60 | | 002799 | 环球即务 | 1 | 9.96 | 32.52 Z | 34.04 | | 300238 | 冠昊生物 | 1 | 7.70 | 49.69 Z | 55.65 | | 603716 | 塞力医疗 | 来 | 5.60 | 60.55 亿 | 339.06 | | 833575 | 康乐卫士 * * | | 4.98 | 47.93亿 | 3.21 | | 002688 | 金河生物 | 1 | 4.62 | 55.94 7, | 64.77 | | 603739 | 蔚蓝生物 | 1 - | 4.41 | 38.31亿 | 27.19 | | 839729 | 永顺生物 | | 3.94 | 27.42 乙 | 53.28 | | 000813 ...

Group 1 - The core viewpoint of the news highlights a surge in virus prevention concept stocks, particularly in response to the release of the 2025 treatment plan for Chikungunya virus, which has led to significant stock price increases for several companies in the pharmaceutical sector [1][2] - Companies such as Lide Man and Lianhuan Pharmaceutical saw their stock prices rise by 20% and nearly 10% respectively, indicating strong market interest and potential investment opportunities in the sector [2] - The news also mentions that there is currently no available vaccine for the Chikungunya virus in China, which may drive demand for preventive measures and related pharmaceutical products [1] Group 2 - Specific stock performance data shows that Hotgen Biotech increased by over 9%, while Zhongsheng Pharmaceutical rose by over 7%, reflecting a broader trend of growth among virus prevention stocks [1][2] - The total market capitalization of Lide Man is reported at 4.597 billion, while Lianhuan Pharmaceutical stands at 5.538 billion, indicating substantial company valuations in the context of the current market dynamics [2] - Year-to-date performance shows that Hotgen Biotech has increased by 244.50%, suggesting a strong upward trend in investor confidence and market performance for this company [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688136 证券简称：科兴制药 公告编号：2025-055 科兴生物制药股份有限公司 股东询价转让定价情况提示性公告 深圳科益医药控股有限公司保证向科兴生物制药股份有限公司（以下简称"公司"）提供的信息内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： ● 根据2025年7月31日询价申购情况，初步确定的本次询价转让价格为36.70元/股。 ● 受让方通过询价转让受让的股份，在受让后6个月内不得转让。 一、本次询价转让初步定价 （一）经向机构投资者询价后，初步确定的转让价格为36.70元/股。 （二）参与本次询价转让报价的机构投资者家数为14家，涵盖了基金管理公司、合格境外机构投资者、 证券公司、保险公司、私募基金管理人等专业机构投资者。参与本次询价转让报价的机构投资者合计有 效认购股份数量为7,050,000股，对应的有效认购倍数为1.17倍。 （三）本次询价转让拟转让股份已获全额认购，初步确定受让方为13家机构投资者 ...